全文获取类型
收费全文 | 873篇 |
免费 | 104篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 35篇 |
妇产科学 | 9篇 |
基础医学 | 161篇 |
口腔科学 | 23篇 |
临床医学 | 80篇 |
内科学 | 143篇 |
皮肤病学 | 15篇 |
神经病学 | 43篇 |
特种医学 | 50篇 |
外科学 | 202篇 |
综合类 | 6篇 |
预防医学 | 69篇 |
眼科学 | 8篇 |
药学 | 32篇 |
中国医学 | 2篇 |
肿瘤学 | 93篇 |
出版年
2021年 | 10篇 |
2019年 | 11篇 |
2018年 | 17篇 |
2017年 | 13篇 |
2015年 | 12篇 |
2014年 | 13篇 |
2013年 | 19篇 |
2012年 | 42篇 |
2011年 | 38篇 |
2010年 | 13篇 |
2009年 | 18篇 |
2008年 | 26篇 |
2007年 | 28篇 |
2006年 | 31篇 |
2005年 | 37篇 |
2004年 | 30篇 |
2003年 | 22篇 |
2002年 | 22篇 |
2001年 | 29篇 |
2000年 | 18篇 |
1999年 | 24篇 |
1998年 | 10篇 |
1997年 | 11篇 |
1996年 | 10篇 |
1993年 | 9篇 |
1992年 | 17篇 |
1991年 | 17篇 |
1990年 | 24篇 |
1989年 | 26篇 |
1988年 | 20篇 |
1987年 | 14篇 |
1986年 | 14篇 |
1985年 | 19篇 |
1984年 | 14篇 |
1983年 | 12篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 31篇 |
1978年 | 24篇 |
1977年 | 28篇 |
1976年 | 12篇 |
1975年 | 19篇 |
1974年 | 23篇 |
1973年 | 18篇 |
1972年 | 22篇 |
1971年 | 12篇 |
1970年 | 8篇 |
1969年 | 11篇 |
1968年 | 9篇 |
1965年 | 10篇 |
排序方式: 共有979条查询结果,搜索用时 171 毫秒
1.
Hommes Franziska Mohsenpour Amir Kropff Dana Pilgram Lisa Matusall Svenja von Philipsborn Peter Sell Kerstin 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(1):96-106
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Akteure der öffentlichen Gesundheit (Public Health) tragen wesentlich zu Gesundheitsschutz, -förderung und... 相似文献
2.
3.
4.
5.
Lisa M. Crisalli Joanne T. Hinkle Christopher C. Walling Mary Sell Noelle V. Frey Elizabeth O. Hexner Alison W. Loren Selina M. Luger Edward A. Stadtmauer David L. Porter Ran Reshef 《Biology of blood and marrow transplantation》2018,24(6):1203-1208
Allogeneic hematopoietic stem cell transplantation (HSCT) with reduced-intensity conditioning (RIC) offers a curative option for patients with hematologic malignancies who are unable to undergo myeloablative conditioning, but its success is limited by high rates of relapse. Several studies have suggested a role for T cell doses in peripheral blood stem cell grafts in RIC HSCT. Because T cell dose is typically not known until after the collection, and apheresis blood volume is easily modifiable, we hypothesized that higher donor apheresis blood volumes would improve transplantation outcomes through an effect on graft composition. Thus, we analyzed the relationships between apheresis volume, graft composition, and transplantation outcomes in 142 consecutive patients undergoing unrelated donor allogeneic RIC HSCT. We found that apheresis volume ≥15 L was associated with a significantly decreased risk of relapse (adjusted hazard ratio [aHR], .48; 95% confidence interval [CI], .28 to .84]; P?=?.01) and improved relapse-free survival (aHR, .56; 95% CI, .35 to .89; P?=?.02) and overall survival (aHR, .55; 95% CI, .34 to .91; P?=?.02). A high apheresis volume was not associated with increased rates of acute or chronic graft-versus-host disease. These results demonstrate that an apheresis volume of at least 15 L is independently predictive of improved transplantation outcomes after RIC allogeneic HSCT. 相似文献
6.
Using a semi-quantitative HL-A antibody adsorption assay, a reduction in HL-A antigenicity was observed in 15 of 22 units of previously frozen and washed red blood cells after passage through a micropore transfusion filter. Red blood cell viability was unaffected by this procedure. Micropore filtration was a simple adjunct to the freezing and washing of red blood cells that may further reduce histocompatibility antigen exposure in transfused recipients. 相似文献
7.
8.
9.
10.
Alessandro Bitto Chad A. Lerner Timothy Nacarelli Elizabeth Crowe Claudio Torres Christian Sell 《Age (Dordrecht, Netherlands)》2014,36(3):1123-1137
Advanced age is characterized by increased incidence of many chronic, noninfectious diseases that impair the quality of living of the elderly and pose a major burden on the healthcare systems of developed countries. These diseases are characterized by impaired or altered function at the tissue and cellular level, which is a hallmark of the aging process. Age-related impairments are likely due to loss of homeostasis at the cellular level, which leads to the accumulation of dysfunctional organelles and damaged macromolecules, such as proteins, lipids, and nucleic acids. Intriguingly, aging and age-related diseases can be delayed by modulating nutrient signaling pathways converging on the target of rapamycin (TOR) kinase, either by genetic or dietary intervention. TOR signaling influences aging through several potential mechanisms, such as autophagy, a degradation pathway that clears the dysfunctional organelles and damaged macromolecules that accumulate with aging. Autophagy substrates are targeted for degradation by associating with p62/SQSTM1, a multidomain protein that interacts with the autophagy machinery. p62/SQSTM1 is involved in several cellular processes, and its loss has been linked to accelerated aging and to age-related pathologies. In this review, we describe p62/SQSTM1, its role in autophagy and in signaling pathways, and its emerging role in aging and age-associated pathologies. Finally, we propose p62/SQSTM1 as a novel target for aging studies and age-extending interventions. 相似文献